Registry-based study finds no evidence linking erenumab treatment to hypertension development in migraine patients, suggesting safety in use.
This study did not find sufficient evidence that treatment with erenumab leads to the development of HT.
No takes yet. Share an insight, caveat, or question.
Lampl et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: